Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are ...

In a major shift for federal drug policy, President Donald Trump signed an executive order on Saturday aimed at accelerating ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and ...

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...

Background: Artificial intelligence-based Clinical Decision Support Systems (AI-CDSS) have enhanced personalized medicine and improved the efficiency of healthcare workers. Despite opportunities, ...

The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...

It has been a bumper year for Denali Therapeutics, Inc. DNLI. Shares of the company have surged 25.4% year to date compared ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies, today acknowledged ...

Design and optimize cardiometabolic trials by addressing complexity, endpoints, recruitment, and regulatory requirements.

Explore how evolving obesity research is shaping trial design, with a focus on precision, reproducibility, and clinical ...

Psyence Biomedical (PBM) stock exploded 203% on April 16, 2026, following White House ibogaine executive order news and ...